Stock A006280 GC BIOPHARMA CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus GC Biopharma Corp.

Equities

A006280

KR7006280002

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-06-06 pm EDT 		5-day change 1st Jan Change
119,900 KRW +1.18% Intraday chart for GC Biopharma Corp. +8.41% -4.46%
May. 20 Gc Biopharma and Novel Pharma Announce Sanfilippo Syndrome Treatment Obtains FDA IND Approval CI
May. 16 GC Biopharma Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Evolution of the average Target Price on GC Biopharma Corp.

Price target over the last 5 years

History of analyst recommendation changes

09ee42b7fdfd.6x_yjy8BFRyXdZs6685zhAwe0yU7t6I83AX9YoD2b38.2VvG3hhieEzmA85Wg4AdsDRkiURU4-x98TaZEtmYF0facr29ejRDRcYt-A~52ba289af1e4cb07740f88af3cbdb1e2

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
119,900 KRW
Average target price
146,333 KRW
Spread / Average Target
+22.05%
High Price Target
150,000 KRW
Spread / Highest target
+25.10%
Low Price Target
140,000 KRW
Spread / Lowest Target
+16.76%

Consensus detail

Consensus revision (last 18 months)

Ratings for GC Biopharma Corp.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. A006280 Stock
  4. Consensus GC Biopharma Corp.